Skip to main content
Top
Published in: Techniques in Coloproctology 5/2014

01-05-2014 | Case Report

Successful treatment for Cronkhite-Canada syndrome with endoscopic mucosal resection and salazosulfapyridine

Authors: H. Ueyama, KI. Fu, K. Ogura, S. Murata, A. Miyazaki

Published in: Techniques in Coloproctology | Issue 5/2014

Login to get access

Abstract

A 79-year-old woman was referred to our hospital because numerous polyps were found in her stomach and large intestine at an ambulatory clinic. Although there were no characteristic symptoms or signs of Cronkhite-Canada syndrome (CCS), endoscopic and pathological findings indicated CCS. Moreover, colonoscopy showed two polypoid lesions (Is type), which appeared neoplastic by magnifying observation with image-enhanced endoscopy (IEE), in the ascending colon. Histologically, the resected specimens revealed tubular adenomas arising in the CCS inflammatory polyps. Remarkable remission of the polyps and edematous mucosa in the stomach and colon was seen after 8 months of administration of salazosulfapyridine (SASP) (3 g/day). Another adenoma was detected and removed endoscopically in the sigmoid colon. This is the first report to describe an asymptomatic case of CCS probably detected in the early phase of the disease, by magnifying IEE which enabled detection and treatment for associated colonic adenomas. SASP was effective in eradication of the inflammatory polyposis, and an additional adenoma was successfully found and removed by surveillance colonoscopy thereafter.
Literature
1.
go back to reference Cronkhite LW Jr, Canada WJ (1955) Generalized gastrointestinal polyposis. An unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med 252:1011–1015PubMedCrossRef Cronkhite LW Jr, Canada WJ (1955) Generalized gastrointestinal polyposis. An unusual syndrome of polyposis, pigmentation, alopecia and onychotrophia. N Engl J Med 252:1011–1015PubMedCrossRef
2.
go back to reference Daniel ES, Ludwig SL, Lewin KJ, Ruprecht RM, Rajacich GM, Schwabe AD (1982) The Cronkhite-Canada syndrome: an analysis of clinical and pathologic features and therapy in 55 patients. Medicine 47:504–510 Daniel ES, Ludwig SL, Lewin KJ, Ruprecht RM, Rajacich GM, Schwabe AD (1982) The Cronkhite-Canada syndrome: an analysis of clinical and pathologic features and therapy in 55 patients. Medicine 47:504–510
3.
go back to reference Parsa C (1982) Cronkhite-Canada syndrome associated with systemic vasculitis: an autopsy study. Hum Pathol 13:758–760PubMedCrossRef Parsa C (1982) Cronkhite-Canada syndrome associated with systemic vasculitis: an autopsy study. Hum Pathol 13:758–760PubMedCrossRef
4.
go back to reference Malhotra R, Sheffield A (1988) Cronkhite-Canada syndrome with colon carcinoma and adenomatous changes in C–C polyps. Am J Gastroenterol 183:772–776 Malhotra R, Sheffield A (1988) Cronkhite-Canada syndrome with colon carcinoma and adenomatous changes in C–C polyps. Am J Gastroenterol 183:772–776
5.
go back to reference Yashiro M, Kobayashi H, Kubo N, Nishiguchi Y, Wakasa K, Hirakawa K (2004) Cronkhite-Canada syndrome containing colon cancer and serrated adenoma lesions. Digestion 69:57–62PubMedCrossRef Yashiro M, Kobayashi H, Kubo N, Nishiguchi Y, Wakasa K, Hirakawa K (2004) Cronkhite-Canada syndrome containing colon cancer and serrated adenoma lesions. Digestion 69:57–62PubMedCrossRef
6.
go back to reference Saeki T, Yokoyama H, Fukuda T et al (1995) Cronkhite-Canada syndrome associated with sigmoid colon cancer. Jpn J Cancer Clin 41:1233–1239 Saeki T, Yokoyama H, Fukuda T et al (1995) Cronkhite-Canada syndrome associated with sigmoid colon cancer. Jpn J Cancer Clin 41:1233–1239
7.
go back to reference Nagata J, Kijima H, Hasumi K, Suzuki T, Shirai T, Mine T (2003) Adenocarcinoma and multiple adenomas of the large intestine, associated with Cronkhite-Canada syndrome. Dig Liver Dis 35:434–438PubMedCrossRef Nagata J, Kijima H, Hasumi K, Suzuki T, Shirai T, Mine T (2003) Adenocarcinoma and multiple adenomas of the large intestine, associated with Cronkhite-Canada syndrome. Dig Liver Dis 35:434–438PubMedCrossRef
8.
go back to reference Jain A, Nanda S, Chakraborty P et al (2003) Cronkhite-Canada syndrome with adenomatous and carcinomatous transformation of colonic polyp. Indian J Gastroenterol 22:189–190PubMed Jain A, Nanda S, Chakraborty P et al (2003) Cronkhite-Canada syndrome with adenomatous and carcinomatous transformation of colonic polyp. Indian J Gastroenterol 22:189–190PubMed
9.
go back to reference Yamashita T, Miyazawa M, Suzuki H (1996) A case of Cronkhite-Canada syndrome improved markedly with antiplasmin agent and steroid. Gastroenterol Endosc 38:45–50 Yamashita T, Miyazawa M, Suzuki H (1996) A case of Cronkhite-Canada syndrome improved markedly with antiplasmin agent and steroid. Gastroenterol Endosc 38:45–50
10.
go back to reference Okamoto K, Isomoto H, Shikuwa S, Nishiyama H, Ito M, Kohno S (2008) A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. Digestion 78:82–87PubMedCrossRef Okamoto K, Isomoto H, Shikuwa S, Nishiyama H, Ito M, Kohno S (2008) A case of Cronkhite-Canada syndrome: remission after treatment with anti-Helicobacter pylori regimen. Digestion 78:82–87PubMedCrossRef
11.
go back to reference Koishi T (1976) A case of Cronkhite-Canada syndrome. Nippon Naika Gakkai Zasshi J Jpn Soc Int Med 65:1060 Koishi T (1976) A case of Cronkhite-Canada syndrome. Nippon Naika Gakkai Zasshi J Jpn Soc Int Med 65:1060
12.
go back to reference Goto A, Shibuya C, Matsunami E (1984) Cronkhite-Canada syndrome. Shokaki Geka 15:111–143 (Seminar) Goto A, Shibuya C, Matsunami E (1984) Cronkhite-Canada syndrome. Shokaki Geka 15:111–143 (Seminar)
13.
go back to reference Kojima E, Tomita A, Matsumura M, Kinoshita M (2009) Magnifying the endoscopic appearance of Cronkhite-Canada syndrome. Gastrointest Endosc 70:1242–1243PubMedCrossRef Kojima E, Tomita A, Matsumura M, Kinoshita M (2009) Magnifying the endoscopic appearance of Cronkhite-Canada syndrome. Gastrointest Endosc 70:1242–1243PubMedCrossRef
14.
go back to reference Itzkowitz SH, Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7–G17PubMedCrossRef Itzkowitz SH, Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7–G17PubMedCrossRef
15.
go back to reference Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO (1994) Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107:117–120PubMed Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO (1994) Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107:117–120PubMed
16.
go back to reference Rutter M, Saunders B, Wilkinson K et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126:451–459PubMedCrossRef Rutter M, Saunders B, Wilkinson K et al (2004) Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126:451–459PubMedCrossRef
17.
go back to reference Gupta RB, Harpaz N, Itzkowitz S et al (2007) Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133:1099–1105PubMedCentralPubMedCrossRef Gupta RB, Harpaz N, Itzkowitz S et al (2007) Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 133:1099–1105PubMedCentralPubMedCrossRef
18.
go back to reference Prantera C, Viscido A, Biancone L, Francavilla A, Giglio L, Campieri M (2005) A new oral delivery system for 5-ASA: preliminary clinical findings for MMx. Inflamm Bowel Dis 11:421–427PubMedCrossRef Prantera C, Viscido A, Biancone L, Francavilla A, Giglio L, Campieri M (2005) A new oral delivery system for 5-ASA: preliminary clinical findings for MMx. Inflamm Bowel Dis 11:421–427PubMedCrossRef
19.
go back to reference D’Haens G, Hommes D, Engels L et al (2006) Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study. Aliment Pharmacol Ther 24:1087–1097PubMedCrossRef D’Haens G, Hommes D, Engels L et al (2006) Once daily MMX mesalazine for the treatment of mild-to-moderate ulcerative colitis: a phase II, dose-ranging study. Aliment Pharmacol Ther 24:1087–1097PubMedCrossRef
20.
go back to reference Prantera C, Rizzi M (2009) 5-ASA in ulcerative colitis: improving treatment compliance. World J Gastroenterol 21:4353–4355CrossRef Prantera C, Rizzi M (2009) 5-ASA in ulcerative colitis: improving treatment compliance. World J Gastroenterol 21:4353–4355CrossRef
21.
go back to reference Suzuki R, Irisawa A, Hikichi T et al (2009) Cronkhite-Canada syndrome associated with myelodysplastic syndrome. World J Gastroenterol 14:5871–5874CrossRef Suzuki R, Irisawa A, Hikichi T et al (2009) Cronkhite-Canada syndrome associated with myelodysplastic syndrome. World J Gastroenterol 14:5871–5874CrossRef
Metadata
Title
Successful treatment for Cronkhite-Canada syndrome with endoscopic mucosal resection and salazosulfapyridine
Authors
H. Ueyama
KI. Fu
K. Ogura
S. Murata
A. Miyazaki
Publication date
01-05-2014
Publisher
Springer Milan
Published in
Techniques in Coloproctology / Issue 5/2014
Print ISSN: 1123-6337
Electronic ISSN: 1128-045X
DOI
https://doi.org/10.1007/s10151-012-0863-0

Other articles of this Issue 5/2014

Techniques in Coloproctology 5/2014 Go to the issue